Summary
This prediction ended on 28.12.15 with a price of €116.10. The prediction for Bayer AG disappointed with a performance of -12.01%. exploration has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | -6.388% | -6.388% | 86.240% | -27.733% |
| iShares Core DAX® | 0.048% | 1.311% | 11.378% | 62.793% |
| iShares Nasdaq 100 | 1.601% | -0.902% | 7.287% | 90.940% |
| iShares Nikkei 225® | 3.057% | 12.947% | 33.767% | 70.774% |
| iShares S&P 500 | 0.820% | 0.703% | 4.930% | 61.763% |
Comments by exploration for this prediction
In the thread Bayer AG diskutieren
Bayer: langfristig positiv
Bayer ist für langfristig orientierte Anleger ein Basisinvestment. Somit können Rückschläge bis 130€ für Käufe getätigt werden. Unter 122€ wird es kritisch.
(Laufzeit überschritten)